Document is current
Any future updates will be listed below
-
Authors
Vidula, Neelima
Blouch, Erica
Hesler, Katherine
Niemierko, Andrzej
Bardia, Aditya
- License Information
-
More Information
Article History
Received: 13 February 2025
Accepted: 17 April 2025
First Online: 25 April 2025
Declarations
:
: NV: Research funding to the institution (MGH): Merck, Daehwa, Radius, Novartis, Pfizer, and Stemline. Advisory board participation (all ended): AbbVie, OncoSec, Gilead, Aadi, TerSera, Novartis, IDEOlogy Health, Daiichi Sankyo, Pfizer. Steering committee participation (ended): Stemline. AB: Editor-in-Chief of Breast Cancer Research and Treatment.
: The study was conducted in accordance with an IRB approved protocol and in line with the principles of the Declaration of Helsinki.
